CBD-Intel

Header Right

Science review sees promise and problems in medical use of CBD

Written by Barnaby Page || 19th February 2019 || Business briefing |

Connecticut
North America
United States
Public Health and Medicine
Business briefing
CBD shows promise for treating some medical conditions but the potential for interactions with other drugs is a cause for concern, as is poor quality control, according to a recent review of science in the field ...

WHO recommends removing CBD from world narcotics schedules

Written by Barnaby Page || 18th February 2019 || Regulatory briefing |

World
Regulation and Legislation
Regulatory briefing
CBD is likely to be removed from the scope of the most significant international treaty on drug control, following a favourable report by the World Health Organization (WHO), which also recommends downgrading cannabis ...

Where in the world are the countries most likely to legalise cannabis?

Written by Barnaby Page || 17th January 2019 || Regulatory briefing |

Africa
Asia
Australasia
Canada
Europe
Mexico
New Zealand
North America
South America
United States
World
Policy and Politics
Regulation and Legislation
Regulatory briefing
Researchers in Portugal have developed an algorithm to identify characteristics that suggest the nations most likely to legalise recreational cannabis ...

Equilibrium to add CBD to recovery shots; new CBD beer hits shelves

Written by Barnaby Page || 30th November 2018 || Business briefing |

England
EU
Europe
Northern Ireland
Scotland
United Kingdom
Wales
Companies
Marketing and Retailing
Business briefing
British detox products supplier Equilibrium Labs is to add CBD to its Sober Up shots next year, in a move that could benefit those with foggy heads thanks to a new CBD beer also hitting shelves. A CBD-infused version...

Don’t judge cannabis by THC/CBD content alone, say scientists

Written by Barnaby Page || 1st November 2018 || Business briefing |

Canada
North America
Public Health and Medicine
Technology and Innovation
Business briefing
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say ...

CBD medicines for animals will need UK government approval

Written by Barnaby Page || 26th September 2018 || Regulatory briefing |

EU
Europe
United Kingdom
Regulation and Legislation
Regulatory briefing
CBD-based medical treatments for animals will need government approval before being sold in the UK, after the country’s Veterinary Medicines Directorate (VMD) decided they fall under the definition of veterinary medicines ...

Sign up to our newsletter

By signing up you agree to our Terms and Conditions